Mechanistically, UCA1 is thought to promote tamoxifen resistance in breast cancer cells by activating the AKT/mTOR signaling pathway, where several additional miRNAs are thought to be involved in the chemoresistance phenomenon [84]. The gene discussed is AKT1; the disease is breast cancer.